Federal contract award
75A50124C00031
A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, WALGREENS, AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATION WITH DECENTRALIZED CARE CAPABILITIES AND TO EXECUTE MORE EFFICIENT AND RELEVANT CLINICAL RESEARCH IN TH
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.5M |
| Current contract value | $3.5M |
| Potential contract value / ceiling | $4.3M |
| Start date | Jul 29, 2024 |
| Current end date | Jul 28, 2029 |
| Potential end date | Jul 28, 2029 |
| Latest award activity | Feb 26, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 26, 2026 | P00003 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING:: NOTIFICATION OF NON-EXERCISE OF OPTION PERIODS AND TERMINATION OF BASE ACTIVITIES OF OTHER TRANSACTION AGREEMENT |
| Mar 31, 2025 | P00002 | $0 | A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, WALGREENS, AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATION WITH DECENTRALIZED CARE CAPABILITIES AND TO EXECUTE MORE EFFICIENT AND RELEVANT CLINICAL RESEARCH IN TH |
| Feb 6, 2025 | P00001 | $0 | A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, WALGREENS, AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATION WITH DECENTRALIZED CARE CAPABILITIES AND TO EXECUTE MORE EFFICIENT AND RELEVANT CLINICAL RESEARCH IN TH |
| Jul 22, 2024 | 0 | $3.5M | A PARTNERSHIP BETWEEN THE AGREEMENT RECIPIENT, WALGREENS, AND BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) TO ENHANCE INNOVATION WITH DECENTRALIZED CARE CAPABILITIES AND TO EXECUTE MORE EFFICIENT AND RELEVANT CLINICAL RESEARCH IN TH |
Estimated positioning window
Jul 28, 2028 – Jan 28, 2029
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-07-28 (1000 days from calculation)
- +15 points
- 22 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-02-26
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.